• 204 Citations
  • 8 h-Index
20002016

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 204 Citations
  • 8 h-Index
  • 14 Article
  • 1 Review article
Filter
Article
2016

Validation of SCT methylation as a hallmark biomarker for lung cancers

Zhang, Y. A., Ma, X., Sathe, A., Fujimoto, J., Wistuba, I. I., Lam, S., Yatabe, Y., Wang, Y. W., Stastny, V., Gao, B., Larsen, J. E., Girard, L., Liu, X., Song, K., Behrens, C., Kalhor, N., Xie, Y., Zhang, M. Q., Minna, J. D. & Gazdar, A. F., Mar 23 2016, In : Journal of Thoracic Oncology. 11, 3, p. 346-360 15 p.

Research output: Contribution to journalArticle

9 Scopus citations
2014

A reevaluation of CD22 expression in human lung cancer

Pop, L. M., Barman, S., Shao, C., Poe, J. C., Venturi, G. M., Shelton, J. M., Pop, I. V., Gerber, D. E., Girard, L., Liu, X. Y., Behrens, C., Rodriguez-Canales, J., Liu, H., Wistuba, I. I., Richardson, J. A., Minna, J. D., Tedder, T. F. & Vitetta, E. S., Jan 1 2014, In : Cancer research. 74, 1, p. 263-271 9 p.

Research output: Contribution to journalArticle

6 Scopus citations
2012
14 Scopus citations
2011
3 Scopus citations
8 Scopus citations
2007

An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity

Miao, Q. F., Liu, X. Y., Shang, B. Y., Ouyang, Z. G. & Zhen, Y. S., Feb 2007, In : Anti-Cancer Drugs. 18, 2, p. 127-137 11 p.

Research output: Contribution to journalArticle

22 Scopus citations

Antitumor effect of pingyangmycin in combination with monoclonal antibody 3G11 directed against type IV collagenase

Liu, X. J., Ouyang, Z. G., Dai, Y., Liu, X. Y. & Zhen, Y. S., Feb 2007, In : Chinese Journal of Cancer Prevention and Treatment. 14, 3, p. 177-180 4 p.

Research output: Contribution to journalArticle

Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin

Miao, Q., Shang, B., Ouyang, Z., Liu, X. & Zhen, Y., Aug 2007, In : Science in China, Series C: Life Sciences. 50, 4, p. 447-456 10 p.

Research output: Contribution to journalArticle

9 Scopus citations
2006

Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics

Liu, X. Y., Pop, L. M., Roopenian, D. C., Ghetie, V., Vitetta, E. S. & Smallshaw, J. E., May 2006, In : International Immunopharmacology. 6, 5, p. 791-799 9 p.

Research output: Contribution to journalArticle

11 Scopus citations
2005
14 Scopus citations
2004

The Evaluation of Recombinant, Chimeric, Tetravalent Antihuman CD22 Antibodies

Meng, R., Smallshaw, J. E., Pop, L. M., Yen, M., Liu, X., Le, L., Ghetie, M. A., Vitetta, E. S. & Ghetie, V., Feb 15 2004, In : Clinical Cancer Research. 10, 4, p. 1274-1281 8 p.

Research output: Contribution to journalArticle

20 Scopus citations
2001
7 Scopus citations

Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody

Liu, X., Shang, B. & Liu, X., Feb 25 2001, In : Zhonghua yi xue za zhi. 81, 4, p. 201-204 4 p.

Research output: Contribution to journalArticle

2 Scopus citations
2000

Antitumor effects of pingyangmycin conjugated with Fab́ fragment of monoclonal antibody

Liu, X. Y., Liu, X. J., Li, Y., Wang, W. G. & Zhen, Y. S., Sep 2000, In : Yaoxue Xuebao. 35, 9, p. 652-653 2 p.

Research output: Contribution to journalArticle